Amiloride
|
Increased risk of hyperkalemia
|
Benazepril
|
Increased risk of hyperkalemia
|
Candesartan
|
Increased risk of hyperkalemia
|
Captopril
|
Increased risk of hyperkalemia
|
Cilazapril
|
Increased risk of hyperkalemia
|
Drospirenone
|
Increased risk of hyperkalemia
|
Enalapril
|
Increased risk of hyperkalemia
|
Eplerenone
|
This association presents an increased risk of hyperkalemia
|
Eprosartan
|
Increased risk of hyperkalemia
|
Forasartan
|
Increased risk of hyperkalemia
|
Fosinopril
|
Increased risk of hyperkalemia
|
Irbesartan
|
Increased risk of hyperkalemia
|
Lisinopril
|
Increased risk of hyperkalemia
|
Lithium
|
The urine alkalizer decreases the effect of lithium
|
Losartan
|
Increased risk of hyperkalemia
|
Moexipril
|
Increased risk of hyperkalemia
|
Perindopril
|
Increased risk of hyperkalemia
|
Polystyrene sulfonate
|
Risk of alkalosis in renal impairment
|
Quinapril
|
Increased risk of hyperkalemia
|
Ramipril
|
Increased risk of hyperkalemia
|
Saprisartan
|
Increased risk of hyperkalemia
|
Spirapril
|
Increased risk of hyperkalemia
|
Spironolactone
|
Increased risk of hyperkalemia
|
Tasosartan
|
Increased risk of hyperkalemia
|
Telmisartan
|
Potassium may increase the hyperkalemic effect of Telmisartan. Monitor serum potassium levels during concomitant use.
|
Trandolapril
|
Increased risk of hyperkalemia
|
Triamterene
|
Increased risk of hyperkalemia
|
Valsartan
|
Increased risk of hyperkalemia
|